Research and Markets: Chronic Plaque Psoriasis Pipeline Review 2015 - 17 Companies & 23 Drug Profiles

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/bhllbj/chronic_plaque) has announced the addition of the "Chronic Plaque Psoriasis - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Chronic Plaque Psoriasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chronic Plaque Psoriasis and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

  • AbGenomics International, Inc.
  • Almirall, S.A.
  • Boehringer Ingelheim GmbH
  • Cellceutix Corporation
  • Coherus BioSciences, Inc.
  • Eli Lilly and Company
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Mitsubishi Tanabe Pharma Corporation
  • Novartis AG
  • OPKO Health, Inc.
  • Pfizer Inc.
  • Sandoz International GmbH
  • Sun Pharma Advanced Research Company Ltd.
  • Takeda Pharmaceutical Company Limited
  • UCB S.A.
  • XenoPort, Inc.

Drug Profiles

  • AbGn-168H
  • adalimumab biosimilar
  • adalimumab biosimilar
  • baricitinib
  • BI-655066
  • C-82
  • certolizumab pegol
  • CJM-112
  • COVA-322
  • dimethyl fumarate
  • etanercept biosimilar
  • etanercept biosimilar
  • etanercept biosimilar
  • GSK-2831781
  • ixekizumab
  • KM-133
  • lunacalcipol
  • MT-1303
  • namilumab
  • orilotimod potassium
  • tildrakizumab
  • tofacitinib
  • XP-23829

For more information visit http://www.researchandmarkets.com/research/bhllbj/chronic_plaque

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Immune Disorders

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Immune Disorders